# US 2003/0229223 A1 · Method for purifying protected 2'-deoxycytidines and hydrated crystals thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0229223 A1
- Document ID: US20030229223A1
- Status: Published application
- Kind: A1
- Application number: 10/453,481
- Filed: 2003-06-04
- Published: 2003-12-11
- Earliest claimed: 2002-06-05
- Assignees: Mitsui Chemicals, Inc.
- Inventors: Hiroki Ishibashi; Kiyoteru Nagahara; Yasushi Fukuiri; Yasuko Matsuba
- Web page: https://patentgrep.com/patent/US20030229223A1

## CPC

- C07H 19/06: Pyrimidine radicals
- C07H 1/06: Separation; Purification
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

A protected 2′-deoxycytidine is purified by precipitating the protected 2′-deoxycytidine represented by general formula (3) in the form of a hydrated crystal from a solution containing the protected 2′-deoxycytidine and water, and by recovering the protected 2′-deoxycytidine: 1 wherein R1 represents a 4-methoxytrityl, 4,4′-dimethoxytrityl, or triphenylmethyl group; and B1 represents a cytosine group having a protected amino group. The compound represented by general formula (3) is, in particular, a protected 2′-deoxycytidine represented by formula (4): 2 The 2′-deoxycytidine is used as a raw material for antisense DNA.

## Claims

### Claim 1

A hydrated crystal of a protected 2′-deoxycytidine represented by general formula (1):
7
wherein each of m and n represents an integer; R1 represents a 4-methoxytrityl, 4,4′-dimethoxytrityl, or triphenylmethyl group; and B1 represents a cytosine group having a protected amino group.

### Claim 2 (depends on 1)

The hydrated crystal of a protected 2′-deoxycytidine according to claim 1 represented by general formula (2):
8
wherein m and n are as defined above.

### Claim 3 (depends on 2)

The hydrated crystal according to claim 2, wherein the content of N4-benzoyl-3′-O-(4,4′-dimethoxytrityl)-2′-deoxycytidine is 0.1% or less.

### Claim 4

A method for purifying a protected 2′-deoxycytidine, comprising precipitating the protected 2′-deoxycytidine represented by general formula (3) in the form of a hydrated crystal from a solution containing the protected 2′-deoxycytidine and water, and recovering the protected 2′-deoxycytidine:
9
wherein R1 and B1 are as defined above.

### Claim 5 (depends on 4)

The method for purifying a protected 2′-deoxycytidine according to claim 4, wherein the content of water in the solution is 0.5 or more equivalents of the compound represented by general formula (3).

### Claim 6 (depends on 4, 5)

The method for purifying a protected 2′-deoxycytidine according to claim 4 or 5, wherein the protected 2′-deoxycytidine is represented by formula (4):
10

### Claim 7 (depends on 6)

The method for purifying a protected 2′-deoxycytidine according to claim 6, wherein the content of N4-benzoyl-3′-O-(4,4′-dimethoxytrityl)-2′-deoxycytidine in the purified crystal is 0.1% or less.

### Claim 8

A method for producing an unhydrated protected 2′-deoxycytidine represented by general formula (3) or formula (4), comprising dehydrating the hydrated crystal of a protected 2′-deoxycytidine represented by general formula (1) or (2) at a reduced pressure.
